Allahabad HC Grants Bail to AMU Professor Accused of Linking Rape to Hindu Scriptures  ||  Supreme Court Vacates Stay on Telangana HC Order Quashing Nomination of 2 MLCs  ||  Supreme Court: Place of Exclusive Jurisdiction Deemed as 'Seat' of Arbitration  ||  Allahabad HC: NCMEI Has Exclusive Power to Grant Minority Status  ||  P&H HC: Default Bail Can Be Granted by Magistrate/Sessions Court Even If Bail Plea Pending Before HC  ||  Allahabad HC Grants Anticipatory Bail to AMU Professor Over Alleged Rape  ||  All HC: Don't Remand Accused to Custody If Chargesheet Filed Sans Arrest  ||  HP High Court: Trial Court Can’t Dictate Investigation Manner, If Remand Purpose Is Clear  ||  Supreme Court: Non-Signatories Have No Right to Attend Arbitration Proceedings  ||  Supreme Court: 'Gender-Neutral' Often Misunderstood As 'Gender Equality'    

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : GLENMARK PHARMACEUTICALS INC   FOREST LABORATORIES   LLC   FOREST LABORATORIES HOLDINGS     ROYALTY PHARMA COLLECTION TRUST  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved